Matarin Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.63M Buy
+16,025
New +$2.34M 0.64% 66
2020
Q2
– Sell
-39,390
Closed -$3.54M – 204
2020
Q1
$3.54M Buy
39,390
+4,621
+13% +$598K 0.55% 88
2019
Q4
$5.14M Sell
34,769
-712
-2% -$95.6K 0.49% 89
2019
Q3
$4.27M Sell
35,481
-68
-0.2% -$8.79K 0.32% 114
2019
Q2
$4.8M Hold
35,549
– – 0.34% 107
2019
Q1
$4.63M Sell
35,549
-143
-0.4% -$19.2K 0.34% 106
2018
Q4
$4.44M Sell
35,692
-192
-0.5% -$25.8K 0.36% 104
2018
Q3
$4.99M Buy
35,884
+7,990
+29% +$995K 0.32% 104
2018
Q2
$2.86M Buy
27,894
+3,569
+15% +$361K 0.21% 149
2018
Q1
$2.36M Buy
+24,325
New +$2.36M 0.18% 165

Other funds holding HCA

Matarin Capital Management's HCA Position: Q4 2020 in Review

Matarin Capital Management opened a new position in HCA Healthcare (HCA) in Q4 2020: 16,025 shares worth $2.63M. The stake represents 0.64% of the portfolio and ranks #66 among its holdings. This is a return to the name: Matarin Capital Management previously reported a position in HCA as recently as Q1 2020.

Matarin Capital Management first reported a position in HCA in Q1 2018 and has held it in 10 quarters since. The position peaked at $5.14M in Q4 2019. 779 funds tracked by Wall St. Rank hold HCA as of Q4 2020.

  • Matarin Capital Management held 16,025 shares of HCA Healthcare worth $2.63M as of Q4 2020.
  • HCA Healthcare was a new Matarin Capital Management position in Q4 2020.
  • HCA Healthcare made up 0.64% of Matarin Capital Management's portfolio in Q4 2020, its #66 holding.
  • Matarin Capital Management first reported a position in HCA Healthcare in Q1 2018 and has held it in 10 quarters since.
  • Matarin Capital Management's HCA Healthcare position peaked at $5.14M in Q4 2019.
  • 779 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.